Form 4 for LFMD LifeMD, Inc.
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-21 · accession 0001362118-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-21 | LFMD | Yecies Eric Harold | GC, CCO | A - Grant | $0.00 | +56.2K | 271.2K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-21 | A | A | 56,250 | $0.00 | 271,250 | D | — | — | (F1) Performance shares vested on March 21, 2024. (F2) The total shares beneficially owned reflect a correction to previously reported ownership. |